International Journal of Analytical Chemistry / 2020 / Article / Tab 2

Research Article

A GC-MS-Based Metabolomics Investigation of the Protective Effect of Liu-Wei-Di-Huang-Wan in Type 2 Diabetes Mellitus Mice

Table 2

Metabolite information of each group after 28 days of treatment.

IdTR (min)Endogenous metabolitesQuantitatively resultsHMDB
MKR groupModel control groupLiu-Wei-Di-Huang groupWestern medicine groupNormal control group

16.563Oxalic acid1.0081 ± 0.06471.1050 ± 0.06381.2981 ± 0.1980.996 ± 0.1261.2671 ± 0.0878HMDB 00190
27.329L-Lactic acid0.1151 ± 0.01760.0670 ± 0.04230.1443 ± 0.0650.0831 ± 0.06390.0708 ± 0.0105HMDB 02329
38.244Butyric acid0.01684 ± 0.00130.01315 ± 0.00190.02088 ± 0.0250.0136 ± 0.00570.023 ± 0.0043HMDB 00357
49.4663-Hydroxybutyric acid0.0261 ± 0.01120.02191 ± 0.0030.01906 ± 0.01220.01847 ± 0.01330.0135 ± 0.027HMDB 00883
510.165Urea0.74953 ± 0.31280.69655 ± 0.10891.19208 ± 0.16390.84024 ± 0.25630.6210 ± 0.0228HMDB 00294
610.756Phosphoric acid0.2025 ± 0.03740.25623 ± 0.03830.30031 ± 0.04060.23334 ± 0.03770.2436 ± 0.096HMDB 02142
711.283L-Proline0.01115 ± 0.01250.00575 ± 0.00920.01983 ± 0.02020.0093 ± 0.00040.0083 ± 0.0024HMDB 00162
811.469Glycine0.02126 ± 0.00540.01324 ± 0.00740.01126 ± 0.01340.00862 ± 0.00750.0724 ± 0.0012HMDB 00123
910.397Serine0.00258 ± 0.00230.00646 ± 0.00690.00137 ± 0.00170.00148 ± 0.00190.00132 ± 0.0009HMDB 00187
1011.185L-Threonine0.02325 ± 0.02260.02313 ± 0.00460.03143 ± 0.03570.02225 ± 0.01060.0235 ± 0.0109HMDB 00167
1114.985L-Aspartic acid0.00942 ± 0.0020.0082 ± 0.00560.00485 ± 0.00420.00481 ± 0.00680.00422 ± 0.0058HMDB 00191
1216.033Erythronic acid0.1006 ± 0.01720.06606 ± 0.01550.10925 ± 0.01360.05299 ± 0.0010.06129 ± 0.0034HMDB 00182
1318.024L-Glutamine0.00405 ± 0.00360.0082 ± 0.00780.00763 ± 0.00620.0088 ± 0.0120.0062 ± 0.0013HMDB 00641
1419.076Citric acid0.05004 ± 0.01050.02826 ± 0.0040.02627 ± 0.00770.02318 ± 0.00530.0136 ± 0.0015HMDB 00094
1519.556N-Acetyl-D-glucosamine0.01069 ± 0.00940.00412 ± 0.00380.00769 ± 0.00250.00142 ± 0.0020.0011 ± 0.0001HMDB 00660
1620.427D-Galactose0.0155 ± 0.00270.01657 ± 0.00170.01977 ± 0.00870.02058 ± 0.00410.00188 ± 0.0041HMDB 00143
1722.175D-Mannose0.01267 ± 0.0120.01474 ± 0.01280.02510 ± 0.00410.01819 ± 0.00130.0186 ± 0.017HMDB 00169
1822.667Mannitol0.44126 ± 0.08530.43875 ± 0.05320.60073 ± 0.10160.46482 ± 0.05440.5924 ± 0.0454HMDB 00143
1922.386D-Glucose1.58832 ± 0.17821.67471 ± 0.09791.27004 ± 0.10111.39533 ± 0.2081.3509 ± 0.1477HMDB 00122
2022.803L-Lysine0.01849 ± 0.0180.00986 ± 0.01040.0481 ± 0.0180.01357 ± 0.00780.0126 ± 0.0010HMDB 00182
2123.076L-Tyrosine0.00374 ± 0.00650.00357 ± 0.00370.02989 ± 0.03050.00216 ± 0.00240.0219 ± 0.0032HMDB 00158
2222.982D-Turanose0.00102 ± 0.00180.0136 ± 0.00620.01904 ± 0.00790.0268 ± 0.00380.0211 ± 0.0016HMDB 11740
2323.734D-Arabinose0.02608 ± 0.01150.1043 ± 0.09430.05253 ± 0.04530.09482 ± 0.08590.0743 ± 0.0161HMDB 29942
2424.877Hexadecanoic acid0.3109 ± 0.01460.27448 ± 0.09680.22018 ± 0.06980.2133 ± 0.03170.15475 ± 0.0359HMDB 00220
2525.411Myo-inositol0.02709 ± 0.00110.04054 ± 0.00430.05513 ± 0.02090.03449 ± 0.00270.00611 ± 0.0018HMDB 00211
2627.025Linoleic acid0.09659 ± 0.01580.14966 ± 0.00970.13681 ± 0.05080.10969 ± 0.0350.1248 ± 0.0049HMDB 00673
2727.1Elaidic acid0.07306 ± 0.01790.10672 ± 0.03860.1192 ± 0.03120.10621 ± 0.05270.1804 ± 0.0036HMDB 00573
2827.404Octadecanoic acid0.1304 ± 0.00400.1216 ± 0.01780.10271 ± 0.0340.10193 ± 0.01150.09816 ± 0.018HMDB 00827
2928.714Arachidonic acid0.0223 ± 0.00160.0252 ± 0.00250.02653 ± 0.01020.0192 ± 0.0090.0141 ± 0.0018HMDB 01043
3032.967Cholesterol0.1060 ± 0.08980.07909 ± 0.07570.0413 ± 0.08370.0323 ± 0.00750.0451 ± 0.0209HMDB 00067

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.